Attention Deficit Hyperactivity Disorder (ADHD) Clinical Research Program
Researchers: Lenard Adler, MD, Vatsal Thakkar, MD and others

This is an interdisciplinary program focused on diagnosis, treatment and pathophysiology of ADHD in adults. Current studies include investigations of novel non-stimulant and stimulant medications.

Stress Disorder Research Program
Researchers: Marion Eakin, MD, Kathlene Tracy, PhD and others

Research on stress disorders is conducted both within the VA environment, focusing largely on Post-Traumatic Stress Disorder (PTSD) and outside of the VA looking at other populations. Currently serving an ethnically diverse population of more than one thousand veterans, this individualized outpatient treatment program is coordinated by a specialized interdisciplinary team including social workers, psychologists, psychiatrists, and primary care clinicians. Treatment includes skills and psychotherapy group treatments, individualized psychotherapies and counseling, and psychopharmacologic management.

Community Research and Recovery Program
Researchers: Kathlene Tracy, PhD, Mark A. Burton, MA, John Rotrosen, MD, Adam Wolkin, MD, Antonio Abad, MD, David Ruhland, PhD, Michael Kramer, PhD and others

The goal of the program is to reduce patients’ psychiatric and substance abuse symptoms by making changes in their daily environment to promote healthier lifestyles. The program promotes the development of innovative approaches that challenge belief systems about limits on patients’ capabilities to improve treatments, reduce associated stigma, and consequently provide environments where persons are more likely to adhere to treatments that match their particular goals in life.

National Drug Abuse Treatment Clinical Trials Network-New York Node
Researchers: John Rotrosen, MD, Paul Casadonte, MD, Malcolm Reid, PhD, Kathlene Tracy, PhD, Agatha Kulaga, MSW, Marc Galanter, MD, Mary Jeanne Kreek, MD, James Robinson, MEd, Scott Kellogg, PhD, Marc Gourevitch, MD, Josh Lee, MD, Steve Kritz, MD, Larry Brown, MD.

The missions of the Clinical Trials Network are (1) to conduct effectiveness studies of behavioral and pharmacological interventions across a wide range of community-based treatment settings in diverse clinical populations, and (2) to disseminate the results of this research to providers and their patients within the community using science as a vehicle. The goal is to translate new medical and behavioral treatments to the broader community. Protocols address substance use disorders, infections and addiction, smoking cessation, issues related to women and trauma, adolescent substance abuse, and HIV/AIDS.

Neurophysiology and Neuropharmacology of Addictive Disorders
Researchers: Malcolm S. Reid, PhD and others

Current research includes a clinical lab to study the neurophysiology and pharmacology of conditioned cocaine and alcohol craving, and clinical treatment trials on experimental pharmacotherapies for drug addiction. The clinical treatment trials involve studies on opiate detoxification, cocaine addiction and smoking cessation. The studies on craving examine the quantitative and neuroanatomical EEG correlates of cocaine and alcohol craving and related anxiety/arousal in response to cue presentation.

Addictions Medication Development
Researchers: Paul Casadonte, MD, John Rotrosen, MD, Malcolm Reid, PhD

We conduct a range of NIH-, VA- and industry- sponsored studies aimed at developing medications to treat addictive disorders. Specific areas of recent focus include dependence on alcohol, nicotine, cocaine, methamphetamine, and opiates such as heroin and prescription pain killers.

Medications Development for Stimulant Dependence
Researchers: Malcolm S. Reid, PhD, Paul Casadonte, MD, John Rotrosen, MD and others

This is a National Institute on Drug Abuse (NIDA) funded program running phase I-III studies to identify and develop pharmacological agents to treat cocaine and amphetamine dependence.

Other Affiliated Research Centers